retatrutide cardiovascular side effects 🔬 — why cardiology and the gym are paying attention For years, peptides lived in bro science or medicine — rarely both. TRIUMPH-4 (Phase 3) changed that. Topline signals: • ~30% What is known about the

This article examines the scientific evidence, potential mechanisms, clinical applications, and important safety considerations surrounding low-dose GLP-1 therapy for inflammatory conditions

Common symptoms include fatigue, weakness, tingling in hands and feet, poor concentration, pale skin, and mood changes

We measure, interpret, and adjust because thats how real change happens. Bryan Jonas, Founder Establish Your Baseline We begin with baseline assessments, including DEXA body composition and labs, to understand exactly where youre starting

However, not every patient qualifies for this therapy

That is a clinically meaningful reduction

50 Exenatide increased IL-10 and Arg-1 levels and decreased TNF-a, IL-1b and iNOS expression, contributing to the conversion of the macrophage phenotype to an anti-inflammatory phenotype